Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 185

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

Deregulation of the signaling pathways controlling urokinase production: Its relationship with the invasive phenotype

Aguirre Ghiso, Julio A., Alonso, Daniel F., Farías, Eduardo F., Gomez, Daniel E., Bal de Kier Joffè, Elisa · 1999 · European Journal of Biochemistry

Abstract

We review the evidence in support of the notion that, upon experimental oncogenic transformation or in spontaneous human cancers, mitogenesis and expression of urokinase (uPA) and its receptor (uPAR) are activated through common signaling complexes and pathways. It is well documented that uPA, uPAR or metalloproteinases (MMPs) are overexpressed in tumor cells of mesenchymal or epithelial origin and these molecules are required for tumor invasion and metastasis. Furthermore, oncogenic stimuli, which may render the transformed cells tumorigenic and metastatic in vivo, activate, in a constitutive fashion, the extracellular‐regulated kinases (Erk 1 and 2) classical mitogenic pathway and others such as the NH 2‐Jun‐kinase (Jnk). Cells from human tumors or oncogene‐transformed cells overexpress uPA and uPAR, and also show a sustained activation of the above‐mentioned signaling modules. In this paper we show that the classical mitogenic pathway involving Ras‐Erk, PKC‐Erk or Rac‐JNK, among others, is activated by growth factors or endogenously by oncogenes, and constitutively activates uPA and uPAR expression. All the data obtained from human tumors or experimental systems, incorporated into a general model, indicate that oncogenic stimuli lead to the constitutive activation of mitogenesis and uPA and its receptor expression, through the activation of the same classical and nonclassical signaling complexes and pathways that regulate cell proliferation. We also discuss contrasting points of view. For instance, what governs the differential regulation of mitogenesis and the signal that leads to protease overexpression in a way that allows normal cells during physiological events to respond to growth factors, and proliferate without overexpressing extracellular matrix (ECM) proteases? Or how can cells remodel their microenvironment without proliferating? What restrains benign tumors from overexpressing tumor‐associated proteases when they certainly have the mitogenic signal fully activated? This may occur by the differential regulation of transcriptional programs and recent reports reviewed in this paper may provide an insight into how this occurs at the signaling and transcriptional levels.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1046/j.1432-1327.1999.00507.x

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 1 references

Cited by

See all 185

Metadata

Authors
Aguirre Ghiso, J. A., Alonso, D. F., Farías, E. F., Gomez, D. E., & Bal de Kier Joffè, E.
Venue
European Journal of Biochemistry
Publisher
Wiley
Published
1999-07-15
Volume
263
Issue
2
Pages
295-304
ISSN
  • 0014-2956 (ISSN-L)
  • 1432-1033
OpenAlex
W1505183758
Cited by
185
References
1
FWCI
4.19
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Deregulation of the signaling pathways controlling urokinase production: Its relationship with the invasive phenotype. https://app.cochat.ai/papers/10.1046/j.1432-1327.1999.00507.x
The paper
Aguirre Ghiso, J. A., Alonso, D. F., Farías, E. F., Gomez, D. E., & Bal de Kier Joffè, E. (1999). Deregulation of the signaling pathways controlling urokinase production: Its relationship with the invasive phenotype. European Journal of Biochemistry. https://doi.org/10.1046/j.1432-1327.1999.00507.x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.